Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer

World Journal of Urology
Felix K H ChunHartwig Huland

Abstract

Radical prostatectomy remains the mainstay for the treatment of localized prostate cancer. Long-term follow-up data showed excellent cancer control rates in several prostatectomy series. We report biochemical recurrence (BCR) outcomes after radical retropubic prostatectomy (RRP) in a European single center series of patients treated over a 13-year period. Between 1992 and 06/2005, 4,277 consecutive men underwent a RRP at the University Hospital Hamburg Eppendorf, Germany. Kaplan-Meier probabilities of BCR-free survival were determined for those patients with complete preoperative data, postoperative data, and follow-up information. Uni-and multivariate Cox regression models addressed PSA recurrence, defined as a PSA level > or = 0.1 ng/ml. Overall, BCR-free survival ranged between 84, 70 and 61% for 2, 5, and 8 years, respectively. In univariate and multivariate analyses, except for age and type of nerve-sparing technique, all traditional clinical and pathological variables represented statistically independent predictors of PSA recurrence-free survival (all P < or = 0.001). In organ-confined disease, the 10-year recurrence free survival rate was 80 and 30% in non-organ-confined cancers. Our findings confirm excellent long-term...Continue Reading

References

Dec 1, 1988·The American Journal of Surgical Pathology·J E McNealT A Stamey
May 30, 1998·Journal of the National Cancer Institute·M W KattanP T Scardino
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M W KattanP T Scardino
Jun 22, 2000·European Urology·J NoldusH Huland
Jan 17, 2002·The Journal of Urology·Gerald W HullPeter T Scardino
Mar 22, 2002·The Journal of Urology·Patrick C Walsh, Pieter J Donker
Sep 25, 2003·Der Urologe. Ausg. A·U MichlH Huland
Dec 8, 2005·European Urology·Markus GraefenHartwig Huland
Feb 14, 2006·The Journal of Urology·Thomas SteuberPierre I Karakiewicz
Jun 7, 2006·The Journal of Urology·Uwe H G MichlHartwig Huland
Jul 4, 2006·The Journal of Urology·Christopher R PorterPierre I Karakiewicz

❮ Previous
Next ❯

Citations

Feb 3, 2011·Langenbeck's Archives of Surgery·Gencay HatibogluMarkus Hohenfellner
Oct 24, 2006·International Journal of Clinical Oncology·Kenichi Tobisu
Jul 4, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F GuedeaM Ventura
Jun 5, 2013·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Catherine PatersonWilliam Lauder
Jun 15, 2007·The New England Journal of Medicine·Donald S KaufmanRobert H Young
Oct 5, 2011·Therapeutic Advances in Urology·Jan SchmitgesMarkus Graefen
May 8, 2013·Future Oncology·Detlef BartkowiakThomas Wiegel
Feb 1, 2014·Endocrine-related Cancer·Won-Mook ChoiHyo-Suk Lee
Jan 16, 2009·Der Urologe. Ausg. A·S SchäfersP Albers
Jul 26, 2011·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Alessandra SiegmannWolfgang Hinkelbein
Nov 7, 2012·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·D BottkeT Wiegel
Sep 8, 2015·Scandinavian Journal of Urology·Michael JanKatarina Bälter
Oct 5, 2010·Urologic Oncology·Herbert AugustinPierre Karakiewicz
Sep 14, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·J LarocheF Bladou
Sep 25, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Dirk BottkeThomas Wiegel
Sep 18, 2009·The Journal of Urology·Yakup KordanDaniel A Barocas
Jun 9, 2009·European Urology·Lars BudäusMarkus Graefen
Dec 17, 2008·The Journal of Urology·Jochen WalzPierre I Karakiewicz
Dec 11, 2007·Urology·David J HernandezAlan W Partin
Jan 16, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Felix K-H ChunPierre I Karakiewicz
Aug 30, 2008·International Journal of Urology : Official Journal of the Japanese Urological Association·Shinya YamamotoIwao Fukui
Aug 30, 2008·International Journal of Urology : Official Journal of the Japanese Urological Association·Venu ChalasaniJonathan I Izawa
Dec 23, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Toyoaki UchidaToshiro Terachi
Jul 5, 2012·BJU International·Marcel HruzaJens Jochen Rassweiler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.